Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol

被引:16
作者
Pan, LP [1 ]
Rosseel, MT [1 ]
Belpaire, FM [1 ]
机构
[1] State Univ Ghent, Sch Med, Heymans Inst Pharmacol, B-9000 Ghent, Belgium
关键词
high-performance liquid chromatography; electrochemical detection; UV detection; intermethod comparison; haloperidol; reduced haloperidol; plasma concentration;
D O I
10.1097/00007691-199804000-00015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Two high-performance liquid chromatographic methods for monitoring haloperidol (HAL) and reduced haloperidol (RHAL) plasma concentrations were compared. In one method ultraviolet detection and a C18 column were used (UV method); in the other method electrochemical detection and a CN-coluInn were used (EC method). Both methods are accurate and precise. For plasma samples spiked with HAL or RHAL, an excellent correlation was observed between the concentrations of HAL and RHAL found with both methods (r less than or equal to 0.99, p < 0.01). However, for plasma obtained from patients treated with HAL the correlation between the two methods was poor (r greater than or equal to 0.71, p < 0.01). The main reason for the discrepancy between the two methods is probably interference of comedications or their metabolites, mostly in the EC method. Although the quantitation limit of the UV method (3 ng/ml for HAL and RHAL) is higher than that of the EC method (0.5 ng/ml for HAL and RHAL), the UV method is to be preferred for monitoring plasma levels in psychiatric patients because there is less interference from comedication.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 17 条
[1]   SIMULTANEOUS DETERMINATION OF PLASMA HALOPERIDOL AND ITS METABOLITE REDUCED HALOPERIDOL BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION - PLASMA-LEVELS IN SCHIZOPHRENIC-PATIENTS TREATED WITH ORAL OR INTRAMUSCULAR DEPOT HALOPERIDOL [J].
ARAVAGIRI, M ;
MARDER, SR ;
VANPUTTEN, T ;
MARSHALL, BD .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 656 (02) :373-381
[2]   HALOPERIDOL AND REDUCED-HALOPERIDOL CONCENTRATIONS IN PLASMA FROM CHRONIC-SCHIZOPHRENIC PATIENTS [J].
AYMARD, N ;
LEYRIS, A ;
TOFFIS, V ;
VIALA, A ;
EPINETTE, C ;
DELTEIL, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (06) :2301-2302
[3]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF HALOPERIDOL AND HYDROXYHALOPERIDOL IN PLASMA AFTER SOLID-PHASE EXTRACTION [J].
CAHARD, C ;
ROP, PP ;
CONQUY, T ;
VIALA, A .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 532 (01) :193-202
[4]   REDUCED HALOPERIDOL - A FACTOR IN DETERMINING THE THERAPEUTIC BENEFIT OF HALOPERIDOL TREATMENT [J].
CHANG, WH .
PSYCHOPHARMACOLOGY, 1992, 106 (03) :289-296
[5]   PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY [J].
DAHL, SG .
CLINICAL PHARMACOKINETICS, 1986, 11 (01) :36-61
[6]   SENSITIVE ELECTROCHEMICAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY FOR THE SIMULTANEOUS DETERMINATION OF HALOPERIDOL AND REDUCED HALOPERIDOL [J].
EDDINGTON, ND ;
YOUNG, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (06) :541-543
[7]   DETERMINATION OF HALOPERIDOL AND REDUCED HALOPERIDOL IN THE PLASMA AND BLOOD OF PATIENTS ON DEPOT HALOPERIDOL [J].
EYLES, DW ;
WHITEFORD, HA ;
STEDMAN, TJ ;
POND, SM .
PSYCHOPHARMACOLOGY, 1992, 106 (02) :268-274
[8]   AN IMPROVED SENSITIVE ASSAY FOR SIMULTANEOUS DETERMINATION OF PLASMA HALOPERIDOL AND REDUCED HALOPERIDOL LEVELS BY LIQUID-CHROMATOGRAPHY USING A COULOMETRIC DETECTOR [J].
HARIHARAN, M ;
KINDT, EK ;
VANNOORD, T ;
TANDON, R .
THERAPEUTIC DRUG MONITORING, 1989, 11 (06) :701-707
[9]  
HILBERT JM, 1991, J CLIN PSYCHIAT, V52, P21
[10]   SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR THERAPEUTIC MONITORING OF HALOPERIDOL LEVELS [J].
HOFFMAN, DW ;
EDKINS, RD .
THERAPEUTIC DRUG MONITORING, 1994, 16 (05) :504-508